UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Post-COVID-19 multiple sclerosis with concomitant herpes simplex virus type 1 meningoencephalitis

Neurology perspectives, 2024-01, Vol.4 (1), p.100142, Article 100142

2024

Volltextzugriff (PDF)

Enfermedad de Alzheimer precipitada por el síndrome de leucoencefalopatía posterior reversible

Neurología (Barcelona, Spain), 2020-05, Vol.35 (4), p.279-282

Ros Forteza, F.J.

2020

Volltextzugriff (PDF)

Alzheimer disease triggered by reversible posterior leukoencephalopathy syndrome

Neurología (Barcelona, English ed. ), 2020-05, Vol.35 (4), p.279-282

Ros Forteza, F.J.

2020

Volltextzugriff (PDF)

Hipertensión intracraneal inducida por minociclina en mujer portadora de dispositivo intrauterino de levonorgestrel

Neurología (Barcelona, Spain), 2019-10, Vol.34 (8), p.551-553

2019

Volltextzugriff (PDF)

Desnutrición en el anciano y encefalopatía de Wernicke

Neurología (Barcelona, Spain), 2019-10, Vol.34 (8), p.543-546

2019

Volltextzugriff (PDF)

Trombólisis segura en astrocitoma de fosa craneal media

Neurología (Barcelona, Spain), 2018-04, Vol.33 (3), p.199-201

2018

Volltextzugriff (PDF)

CN52 Role of translational oncology research nurse (TORN) in improving patients (pts) adherence to microbiome research projects

Annals of oncology, 2023-10, Vol.34, p.S1240-S1240

2023

Volltextzugriff (PDF)

2055P Multidisciplinary Tumor-ICU Board: Enhancing care for critically Ill patients with solid tumors in the ICU

Annals of oncology, 2023-10, Vol.34, p.S1086-S1086

2023

Volltextzugriff (PDF)

445P Tumor load surrogates as major prognostic factors in BRAF-V600E mutated (mt) colorectal (CRC) patients treated with BRAF inhibitor+antiEGFR +/- MEK inhibitor

Annals of oncology, 2021-09, Vol.32, p.S556-S556

2021

Volltextzugriff (PDF)

499P Heterogeneity in the immune inflamed biomarkers of MSS and MSI colorectal cancer

Annals of oncology, 2020-09, Vol.31, p.S452-S452

2020

Volltextzugriff (PDF)

380P Ten-year experience of the Vall d’Hebron Institute of Oncology early drug development unit (VHIO-UITM) treating patients (pts) with primary CNS tumours (pCNS)

Annals of oncology, 2020-09, Vol.31, p.S403-S403

2020

Volltextzugriff (PDF)

487P Use of patient-derived tumour organoids to identify acquired treatment resistance and determine optimal post-progression combinations in metastatic colorectal cancer

Annals of oncology, 2020-09, Vol.31, p.S447-S447

2020

Volltextzugriff (PDF)

121P Early and easy-to-retrieve predictive biomarkers of resistance to immunotherapy in microsatellite instability (MSI)/mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC)

Annals of oncology, 2024-06, Vol.35, p.S56-S57

2024

Volltextzugriff (PDF)

125P Circulating tumour DNA (ctDNA) as a prognostic biomarker in patients (pts) with refractory metastatic colorectal cancer (mCRC) receiving TAS102 with or without bevacizumab

Annals of oncology, 2024-06, Vol.35, p.S58-S59

2024

Volltextzugriff (PDF)

88P Real-world data of patients (pts) with BRAF V600E-mutated (mt) metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD–TPI)

Annals of oncology, 2024-06, Vol.35, p.S43-S43

2024

Volltextzugriff (PDF)

626P Mucinous differentiation (MD) as predictor of response in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with BRAF inhibitors (BRAFi) combinations

Annals of oncology, 2023-10, Vol.34, p.S447-S447

2023

Volltextzugriff (PDF)

76P Association of clinicopathological (C-P) features and tumor (tum) immune contexture with dissemination pattern in metastatic colorectal cancer (mCRC)

Annals of oncology, 2024-06, Vol.35, p.S37-S38

2024

Volltextzugriff (PDF)

Reliable and Efficient Broadcasting in Vehicular Ad Hoc Networks

VTC Spring 2009 - IEEE 69th Vehicular Technology Conference, 2009, p.1-5

2009

Volltextzugriff (PDF)

357P Novel potential predictive biomarker to immunotherapy (Io) treatment in metastatic colorectal cancer (mCRC) patients: The role of the VHIO immune gene-expression signature (VIGex)

Annals of oncology, 2022-09, Vol.33, p.S699

2022

Volltextzugriff (PDF)

374P Influence of sex on safety and efficacy in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with encorafenib-cetuximab +/-binimetinib (E-C+/-B)

Annals of oncology, 2022-09, Vol.33, p.S707

2022

Volltextzugriff (PDF)

Malnutrition and Wernicke encephalopathy in the elderly

Neurología (Barcelona, English ed. ), 2019-10, Vol.34 (8), p.543-546

2019

Volltextzugriff (PDF)

Minocycline-induced intracranial hypertension in a patient with a levonorgestrel intrauterine device

Neurología (Barcelona, English ed. ), 2019-10, Vol.34 (8), p.551-553

2019

Volltextzugriff (PDF)

332P Impact of the COVID-19 pandemic in the early-onset colorectal cancer (EOCRC)

Annals of oncology, 2022-09, Vol.33, p.S689-S689

2022

Volltextzugriff (PDF)

290P Potential enrichment strategies for next-generation sequencing (NGS) in primary brain cancers (pBCs) in a clinical series according to ESMO scale for clinical actionability of molecular targets (ESCAT)

Annals of oncology, 2022-09, Vol.33, p.S671-S672

2022

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(19)
Humans
(11)
Technology
(11)
Engineering
(7)
Female
(7)
Internal Medicine
(7)
Biological And Medical Sciences
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Physical Sciences
(6)
Male
(5)
Animals
(4)
Computer Science
(4)
Nutrition & Dietetics
(4)
Studies
(4)
Time Factors
(4)
Ad Hoc Networks
(3)
Aged
(3)
Composite Resins - Chemistry
(3)
Computer Architecture
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Post-COVID-19 multiple sclerosis with concomitant herpes simplex virus type 1 meningoencephalitis

Enfermedad de Alzheimer precipitada por el síndrome de leucoencefalopatía posterior reversible

Alzheimer disease triggered by reversible posterior leukoencephalopathy syndrome

Hipertensión intracraneal inducida por minociclina en mujer portadora de dispositivo intrauterino de levonorgestrel

Desnutrición en el anciano y encefalopatía de Wernicke

Trombólisis segura en astrocitoma de fosa craneal media

CN52 Role of translational oncology research nurse (TORN) in improving patients (pts) adherence to microbiome research projects

2055P Multidisciplinary Tumor-ICU Board: Enhancing care for critically Ill patients with solid tumors in the ICU

445P Tumor load surrogates as major prognostic factors in BRAF-V600E mutated (mt) colorectal (CRC) patients treated with BRAF inhibitor+antiEGFR +/- MEK inhibitor

499P Heterogeneity in the immune inflamed biomarkers of MSS and MSI colorectal cancer

380P Ten-year experience of the Vall d’Hebron Institute of Oncology early drug development unit (VHIO-UITM) treating patients (pts) with primary CNS tumours (pCNS)

487P Use of patient-derived tumour organoids to identify acquired treatment resistance and determine optimal post-progression combinations in metastatic colorectal cancer

121P Early and easy-to-retrieve predictive biomarkers of resistance to immunotherapy in microsatellite instability (MSI)/mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC)

125P Circulating tumour DNA (ctDNA) as a prognostic biomarker in patients (pts) with refractory metastatic colorectal cancer (mCRC) receiving TAS102 with or without bevacizumab

88P Real-world data of patients (pts) with BRAF V600E-mutated (mt) metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD–TPI)

626P Mucinous differentiation (MD) as predictor of response in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with BRAF inhibitors (BRAFi) combinations

76P Association of clinicopathological (C-P) features and tumor (tum) immune contexture with dissemination pattern in metastatic colorectal cancer (mCRC)

Reliable and Efficient Broadcasting in Vehicular Ad Hoc Networks

357P Novel potential predictive biomarker to immunotherapy (Io) treatment in metastatic colorectal cancer (mCRC) patients: The role of the VHIO immune gene-expression signature (VIGex)

374P Influence of sex on safety and efficacy in BRAF-V600E mutated metastatic colorectal cancer (mCRC) treated with encorafenib-cetuximab +/-binimetinib (E-C+/-B)

Malnutrition and Wernicke encephalopathy in the elderly

Minocycline-induced intracranial hypertension in a patient with a levonorgestrel intrauterine device

332P Impact of the COVID-19 pandemic in the early-onset colorectal cancer (EOCRC)

126P The HLA I composite score and VHIO immune gene-expression signature (VIGex) as selection tools to explore the tumor microenvironment (TME) in patients (pts) treated with immunotherapy (IT)

290P Potential enrichment strategies for next-generation sequencing (NGS) in primary brain cancers (pBCs) in a clinical series according to ESMO scale for clinical actionability of molecular targets (ESCAT)

Suchergebnisse filtern